Sunflower Pharmaceuticals Group Co Ltd Asset Resilience Ratio

Latest as of March 2026: 22.45%

Sunflower Pharmaceuticals Group Co Ltd asset resilience ratio. Sunflower Pharmaceuticals Group Co Ltd (002737) has an Asset Resilience Ratio of 22.45% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Sunflower Pharmaceuticals Group Co Ltd (002737) liquidity interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥1.20 Billion

≈ $175.97 Million USD Cash + Short-term Investments

Total Assets

CN¥5.36 Billion

≈ $783.70 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio of Sunflower Pharmaceuticals Group Co Ltd (2016–2025)

Asset resilience ratio of Sunflower Pharmaceuticals Group Co Ltd from 2016 to 2025. This chart shows how Sunflower Pharmaceuticals Group Co Ltd's Asset Resilience Ratio has changed over time. Read Sunflower Pharmaceuticals Group Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Sunflower Pharmaceuticals Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Sunflower Pharmaceuticals Group Co Ltd balance sheet assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.20 Billion	22.45%
Total Liquid Assets	CN¥1.20 Billion	22.45%

Asset Resilience Insights

Good Liquidity Position: Sunflower Pharmaceuticals Group Co Ltd maintains a healthy 22.45% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Sunflower Pharmaceuticals Group Co Ltd Industry Peers by Asset Resilience Ratio

Compare Sunflower Pharmaceuticals Group Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Sandoz Group AG SW:SDZ	Drug Manufacturers - Specialty & Generic	7.89%
H Lundbeck A/S CO:HLUN-B	Drug Manufacturers - Specialty & Generic	-0.56%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Viyash Scientific Limited NSE:SEQUENT	Drug Manufacturers - Specialty & Generic	0.08%
Anhui Fengyuan Pharmaceutical Co Ltd SHE:000153	Drug Manufacturers - Specialty & Generic	1.81%

Sunflower Pharmaceuticals Group Co Ltd Asset Resilience Ratio by Year (2016–2025)

Sunflower Pharmaceuticals Group Co Ltd asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for Sunflower Pharmaceuticals Group Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	32.94%	CN¥1.76 Billion ≈ $256.85 Million	CN¥5.33 Billion ≈ $779.70 Million	+11.34pp
2024-12-31	21.60%	CN¥1.26 Billion ≈ $184.12 Million	CN¥5.83 Billion ≈ $852.51 Million	+2.49pp
2023-12-31	19.11%	CN¥1.32 Billion ≈ $192.44 Million	CN¥6.88 Billion ≈ $1.01 Billion	-1.49pp
2022-12-31	20.60%	CN¥1.45 Billion ≈ $211.99 Million	CN¥7.03 Billion ≈ $1.03 Billion	+8.74pp
2021-12-31	11.87%	CN¥668.69 Million ≈ $97.85 Million	CN¥5.64 Billion ≈ $824.61 Million	+8.92pp
2020-12-31	2.94%	CN¥150.49 Million ≈ $22.02 Million	CN¥5.11 Billion ≈ $748.24 Million	-0.92pp
2019-12-31	3.86%	CN¥205.00 Million ≈ $30.00 Million	CN¥5.31 Billion ≈ $776.92 Million	-0.95pp
2018-12-31	4.81%	CN¥243.46 Million ≈ $35.63 Million	CN¥5.06 Billion ≈ $740.31 Million	-0.87pp
2017-12-31	5.68%	CN¥254.00 Million ≈ $37.17 Million	CN¥4.47 Billion ≈ $654.13 Million	-0.43pp
2016-12-31	6.11%	CN¥258.00 Million ≈ $37.75 Million	CN¥4.22 Billion ≈ $618.05 Million	--

pp = percentage points

About Sunflower Pharmaceuticals Group Co Ltd

SHE:002737 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.03 Billion

CN¥7.04 Billion CNY

Market Cap Rank

#8492 Global

#1946 in China

Share Price

CN¥12.06

Change (1 day)

-0.74%

52-Week Range

CN¥11.11 - CN¥15.35

All Time High

CN¥28.79